A map of the conversation
People use peptides for a handful of reasons. We’ll look at the conversation at a high level before taking a closer look at individual compounds.
Three useful buckets are growth-related goals, repair claims, and metabolism. They organize this lesson; they are not a formal classification or a list of proven benefits.
Growth-related goals
CJC-1295 is studied because it can stimulate the body’s release of growth . People seek compounds in this group for recovery, better sleep, body composition, and anti-aging.
Early human studies measured changes. That is not the same as demonstrating those hoped-for benefits or establishing long-term safety.
Repair claims
BPC-157 and TB-500 are promoted for soft-tissue, tendon, and gut repair. These are claims to examine, not established healing effects in people.
Much of the discussion draws on laboratory or animal research. Limited human reports do not establish broad healing benefits, and important safety questions remain.
Metabolism
This group includes semaglutide and tirzepatide, names behind widely discussed weight-management medicines. Semaglutide acts on GLP-1 receptors—say “GLP-one.” Tirzepatide acts on both GIP and GLP-1 receptors.
Specific approved medicines have evidence from human trials for defined medical uses. That evidence applies to those products and uses, not to every or every product sold under a similar name.
Beyond those three buckets
You will also see peptides discussed for focus, mood, immune support, longevity, libido, and tanning. Evidence and approval depend on the exact substance and intended use. A narrow medical indication is not proof of a broad wellness claim.
Popular does not mean proven
A controlled human study, an animal experiment, and a personal story on a forum answer different questions. A ’s popularity does not tell you which kind of evidence supports a claim.
Next in the notebook: how to tell those sources of evidence apart.